PHARMASSET INC Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 42 rows, 42 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2007-05-04: Reporting owner BURRILL STEVEN; Form 3/A; Security Series D convertible preferred stock; Transaction Holding.
- 2007-05-04: Reporting owner BURRILL STEVEN; Form 3/A; Security Series D convertible preferred stock; Transaction Holding.
- 2007-05-04: Reporting owner BURRILL STEVEN; Form 3/A; Security Series D-1 preferred stock warrant (right to buy); Transaction Holding.
- 2007-05-04: Reporting owner BURRILL STEVEN; Form 3/A; Security Series D-1 preferred stock warrant (right to buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2007-05-04 holding as of filing | BURRILL STEVEN Director | 3/A | Series D convertible preferred stock Derivative · Indirect · By Fund | Holding | no price filed | 2007-05-04 | ||
| 2007-05-04 holding as of filing | BURRILL STEVEN Director | 3/A | Series D convertible preferred stock Derivative · Indirect · By Fund | Holding | no price filed | 2007-05-04 | ||
| 2007-05-04 holding as of filing | BURRILL STEVEN Director | 3/A | Series D-1 preferred stock warrant (right to buy) Derivative · Indirect · By Fund | Holding | $0.15 exercise price | 2007-05-04 | ||
| 2007-05-04 holding as of filing | BURRILL STEVEN Director | 3/A | Series D-1 preferred stock warrant (right to buy) Derivative · Indirect · By Fund | Holding | $0.15 exercise price | 2007-05-04 | ||
| 2007-05-02 | Schinazi Raymond F 10% Owner | 4/A | Series A convertible preferred stock Derivative · Direct | C Conversion of derivative security | −369,179 0 owned after | $0.00 | 2007-05-04 | |
| 2007-05-02 | GADICKE ANSBERT Director, 10% Owner | 4 | Warrant to purchase Series D-1 Preferred Stock Derivative · Indirect · See Footnote | X Exercise of in-the-money or at-the-money derivative security | −382,365 0 owned after | $0.10 exercise price | 2007-05-04 | |
| 2007-05-02 | GADICKE ANSBERT Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −367,999 0 owned after | $0.00 | 2007-05-04 | |
| 2007-05-02 | GADICKE ANSBERT Director, 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −1,076,231 0 owned after | $0.00 | 2007-05-04 | |
| 2007-05-02 | MPM BIOVENTURES I LP | MPM BIO VENTURES I LLC | MPM ASSET MANAGEMENT INVESTORS 1999 LLC | BAB BIO VENTURES LLP | BB BIOVENTURES L P | BAB BIO VENTURES NV | EVNIN LUKE | STEINMETZ MICHAEL | MPM BIOVENTURES PARALLEL FUND L P 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Warrant to purchase Series D-1 Preferred Stock Derivative · Indirect · See Footnote | X Exercise of in-the-money or at-the-money derivative security | −382,365 0 owned after | $0.10 exercise price | 2007-05-04 | |
| 2007-05-02 | MPM BIOVENTURES I LP | MPM BIO VENTURES I LLC | MPM ASSET MANAGEMENT INVESTORS 1999 LLC | BAB BIO VENTURES LLP | BB BIOVENTURES L P | BAB BIO VENTURES NV | EVNIN LUKE | STEINMETZ MICHAEL | MPM BIOVENTURES PARALLEL FUND L P 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −367,999 0 owned after | $0.00 | 2007-05-04 | |
| 2007-05-02 | MPM BIOVENTURES I LP | MPM BIO VENTURES I LLC | MPM ASSET MANAGEMENT INVESTORS 1999 LLC | BAB BIO VENTURES LLP | BB BIOVENTURES L P | BAB BIO VENTURES NV | EVNIN LUKE | STEINMETZ MICHAEL | MPM BIOVENTURES PARALLEL FUND L P 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −1,076,231 0 owned after | $0.00 | 2007-05-04 | |
| 2007-05-02 | MPM BIOVENTURES III LLC | MPM BIOVENTURES III LP | MPM Asset Management Investors 2004 BVIII LLC | MPM BIOVENTURES III GMBH & CO. Beteiligungs KG | MPM BIOVENTURES III PARALLEL FUND, LP | MPM BIOVENTURES III QP LP | MPM BIOVENTURES III GP LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Warrant to purchase Series D-1 Preferred Stock Derivative · Indirect · See Footnote | X Exercise of in-the-money or at-the-money derivative security | −323,529 0 owned after | $0.10 exercise price | 2007-05-04 | |
| 2007-05-02 | MPM BIOVENTURES III LLC | MPM BIOVENTURES III LP | MPM Asset Management Investors 2004 BVIII LLC | MPM BIOVENTURES III GMBH & CO. Beteiligungs KG | MPM BIOVENTURES III PARALLEL FUND, LP | MPM BIOVENTURES III QP LP | MPM BIOVENTURES III GP LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −910,628 0 owned after | $0.00 | 2007-05-04 | |
| 2007-05-02 | SIMON NICHOLAS J III | HENNER DENNIS | WHEELER KURT | GALAKATOS NICHOLAS 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Warrant to purchase Series D-1 Preferred Stock Derivative · Indirect · See Footnote | X Exercise of in-the-money or at-the-money derivative security | −323,529 0 owned after | $0.10 exercise price | 2007-05-04 | |
| 2007-05-02 | SIMON NICHOLAS J III | HENNER DENNIS | WHEELER KURT | GALAKATOS NICHOLAS 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −910,628 0 owned after | $0.00 | 2007-05-04 | |
| 2007-05-02 | Schinazi Raymond F 10% Owner | 4 | Series A convertible preferred stock Derivative · Direct | C Conversion of derivative security | −369,179 0 owned after | $0.00 | 2007-05-04 | |
| 2007-05-02 | BURRILL STEVEN Director | 4 | Series D preferred stock Derivative · Indirect · See footnote | C Conversion of derivative security | −582,375 0 owned after | $0.00 | 2007-05-04 | |
| 2007-04-27 | TVM V LIFE SCIENCE VENTURES GMBH & CO KG | TVM V Life Science Ventures Management GmbH & Co. KG 10% Owner | 10% Owner | 4 | Series D Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −176,476 0 owned after | $0.00 | 2007-05-01 | |
| 2007-04-27 | TVM V LIFE SCIENCE VENTURES GMBH & CO KG | TVM V Life Science Ventures Management GmbH & Co. KG 10% Owner | 10% Owner | 4 | Series D-1 Preferred Stock Warrant (right to buy) Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −98,043 0 owned after | $0.10 exercise price | 2007-05-01 | |
| 2007-04-27 | TVM IV Management GmbH & Co. KG | TVM IV GMBH & CO KG 10% Owner | 10% Owner | 4 | Series C Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −250,121 0 owned after | $0.00 | 2007-05-01 | |
| 2007-04-27 | TVM IV Management GmbH & Co. KG | TVM IV GMBH & CO KG 10% Owner | 10% Owner | 4 | Series D-1 Preferred Stock Warrant (right to buy) Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −52,302 0 owned after | $0.10 exercise price | 2007-05-01 | |
| 2007-04-26 holding as of filing | BURRILL LIFE SCIENCES CAPITAL FUND LP | Burrill Indiana Life Sciences Capital Fund, L.P. | Burrill & CO (Indiana GP), LLC | Burrill & CO (Life Sciences GP), LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series D Preferred Stock Derivative · Indirect · See footnotes | Holding | no price filed | 2007-04-26 | ||
| 2007-04-26 holding as of filing | TVM IV GMBH & CO KG | TVM IV Management GmbH & Co. KG 10% Owner | 10% Owner | 3 | Series C Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2007-04-26 | ||
| 2007-04-26 holding as of filing | TVM IV GMBH & CO KG | TVM IV Management GmbH & Co. KG 10% Owner | 10% Owner | 3 | Series D-1 preferred stock warrant (right to buy) Derivative · Indirect · See footnote | Holding | $0.10 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | TVM V LIFE SCIENCE VENTURES GMBH & CO KG | TVM V Life Science Ventures Management GmbH & Co. KG 10% Owner | 10% Owner | 3 | Series D Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2007-04-26 | ||
| 2007-04-26 holding as of filing | TVM V LIFE SCIENCE VENTURES GMBH & CO KG | TVM V Life Science Ventures Management GmbH & Co. KG 10% Owner | 10% Owner | 3 | Series D-1 preferred stock warrant (right to buy) Derivative · Indirect · See footnote | Holding | $0.10 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | HENNER DENNIS | GALAKATOS NICHOLAS | WHEELER KURT | SIMON NICHOLAS J III 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Warrant to purchase Series D-1 Preferred Stock Derivative · Indirect · See Footnote | Holding | $1.50 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | HENNER DENNIS | GALAKATOS NICHOLAS | WHEELER KURT | SIMON NICHOLAS J III 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series D Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2007-04-26 | ||
| 2007-04-26 holding as of filing | MPM BIOVENTURES III PARALLEL FUND, LP | MPM BIOVENTURES III QP LP | MPM BIOVENTURES III LP | MPM BIOVENTURES III GMBH & CO. Beteiligungs KG | MPM Asset Management Investors 2004 BVIII LLC | MPM BIOVENTURES III GP LP | MPM BIOVENTURES III LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Warrant to purchase Series D-1 Preferred Stock Derivative · Indirect · See Footnote | Holding | $1.50 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | MPM BIOVENTURES III PARALLEL FUND, LP | MPM BIOVENTURES III QP LP | MPM BIOVENTURES III LP | MPM BIOVENTURES III GMBH & CO. Beteiligungs KG | MPM Asset Management Investors 2004 BVIII LLC | MPM BIOVENTURES III GP LP | MPM BIOVENTURES III LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series D Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2007-04-26 | ||
| 2007-04-26 holding as of filing | GADICKE ANSBERT Director, 10% Owner | 3 | Warrant to purchase Series D-1 Preferred Stock Derivative · Indirect · See Footnote | Holding | $1.50 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | GADICKE ANSBERT Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2007-04-26 | ||
| 2007-04-26 holding as of filing | GADICKE ANSBERT Director, 10% Owner | 3 | Series D Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2007-04-26 | ||
| 2007-04-26 holding as of filing | EVNIN LUKE | MPM BIOVENTURES I LP | MPM BIO VENTURES I LLC | MPM BIOVENTURES PARALLEL FUND L P | STEINMETZ MICHAEL | MPM ASSET MANAGEMENT INVESTORS 1999 LLC | BB BIOVENTURES L P | BAB BIO VENTURES LLP | BAB BIO VENTURES NV 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Warrant to purchase Series D-1 Preferred Stock Derivative · Indirect · See Footnote | Holding | $1.50 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | EVNIN LUKE | MPM BIOVENTURES I LP | MPM BIO VENTURES I LLC | MPM BIOVENTURES PARALLEL FUND L P | STEINMETZ MICHAEL | MPM ASSET MANAGEMENT INVESTORS 1999 LLC | BB BIOVENTURES L P | BAB BIO VENTURES LLP | BAB BIO VENTURES NV 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2007-04-26 | ||
| 2007-04-26 holding as of filing | EVNIN LUKE | MPM BIOVENTURES I LP | MPM BIO VENTURES I LLC | MPM BIOVENTURES PARALLEL FUND L P | STEINMETZ MICHAEL | MPM ASSET MANAGEMENT INVESTORS 1999 LLC | BB BIOVENTURES L P | BAB BIO VENTURES LLP | BAB BIO VENTURES NV 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series D Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2007-04-26 | ||
| 2007-04-26 holding as of filing | Schinazi Raymond F 10% Owner | 3 | Series A convertible preferred stock Derivative · Direct | Holding | no price filed | 2007-04-26 | ||
| 2007-04-26 holding as of filing | BURRILL STEVEN Director | 3 | Series D convertible preferred stock Derivative · Indirect · By Fund | Holding | no price filed | 2007-04-26 | ||
| 2007-04-26 holding as of filing | BURRILL STEVEN Director | 3 | Series D convertible preferred stock Derivative · Indirect · By Fund | Holding | no price filed | 2007-04-26 | ||
| 2007-04-26 holding as of filing | BURRILL STEVEN Director | 3 | Series D-1 preferred stock warrant (right to buy) Derivative · Indirect · By Fund | Holding | $0.10 exercise price | 2007-04-26 | ||
| 2007-04-26 holding as of filing | BURRILL STEVEN Director | 3 | Series D-1 preferred stock warrant (right to buy) Derivative · Indirect · By Fund | Holding | $0.10 exercise price | 2007-04-26 | ||
| 2006-05-02 | BURRILL LIFE SCIENCES CAPITAL FUND LP | Burrill & CO (Life Sciences GP), LLC | Burrill & CO (Indiana GP), LLC | Burrill Indiana Life Sciences Capital Fund, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · See Footnotes | C Conversion of derivative security | −582,375 0 owned after | $0.00 | 2007-05-04 |